EP1019404A4 - Purine acyclonucleosides as antiviral agents - Google Patents

Purine acyclonucleosides as antiviral agents

Info

Publication number
EP1019404A4
EP1019404A4 EP98942377A EP98942377A EP1019404A4 EP 1019404 A4 EP1019404 A4 EP 1019404A4 EP 98942377 A EP98942377 A EP 98942377A EP 98942377 A EP98942377 A EP 98942377A EP 1019404 A4 EP1019404 A4 EP 1019404A4
Authority
EP
European Patent Office
Prior art keywords
acyclonucleosides
purine
antiviral agents
antiviral
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98942377A
Other languages
German (de)
French (fr)
Other versions
EP1019404A1 (en
Inventor
Sebastian Mario Marcuccio
Karen Elizabeth Jarvis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Publication of EP1019404A1 publication Critical patent/EP1019404A1/en
Publication of EP1019404A4 publication Critical patent/EP1019404A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36—Sulfur atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP98942377A 1997-09-11 1998-09-11 Purine acyclonucleosides as antiviral agents Withdrawn EP1019404A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPO9129A AUPO912997A0 (en) 1997-09-11 1997-09-11 Antiviral agents
AUPO912997 1997-09-11
PCT/AU1998/000748 WO1999012927A1 (en) 1997-09-11 1998-09-11 Purine acyclonucleosides as antiviral agents

Publications (2)

Publication Number Publication Date
EP1019404A1 EP1019404A1 (en) 2000-07-19
EP1019404A4 true EP1019404A4 (en) 2001-07-04

Family

ID=3803414

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98942377A Withdrawn EP1019404A4 (en) 1997-09-11 1998-09-11 Purine acyclonucleosides as antiviral agents

Country Status (9)

Country Link
EP (1) EP1019404A4 (en)
JP (1) JP2001515900A (en)
KR (1) KR20010023890A (en)
CN (1) CN1269801A (en)
AU (1) AUPO912997A0 (en)
CA (1) CA2302630A1 (en)
ID (1) ID26937A (en)
NZ (1) NZ502994A (en)
WO (1) WO1999012927A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI20022A (en) * 1998-07-29 2000-02-29 Kemijski inštitut Alkyl substituted purine derivatives and their preparation
KR100377138B1 (en) * 1998-11-10 2003-06-12 주식회사 엘지생명과학 Cyclin's Zonkinase Inhibitor with Purine Structure, Methods for Making the Same, and Anticancer Compositions Containing the Same
GB9903762D0 (en) 1999-02-18 1999-04-14 Novartis Ag Organic compounds
JP2003530329A (en) * 2000-04-07 2003-10-14 ユニヴァーシティ オブ メリーランド，ボルチモア Bile acid-containing prodrugs with increased bioavailability
JP4397691B2 (en) 2001-10-30 2010-01-13 コンフォーマ・セラピューティクス・コーポレイション Purine analogs having HSP90 inhibitory activity
AU2003279690A1 (en) * 2002-06-27 2004-01-19 F. Hoffmann-La Roche Ag Synthesis of purine derivatives
US20060128956A1 (en) * 2003-04-21 2006-06-15 Ustav Organicke Chemie A Biochemie Akademie Ved Ceske Republiky (Purin-6-yl) amino acid and production method thereof
KR20060070572A (en) 2003-09-18 2006-06-23 콘포마 세러퓨틱스 코포레이션 Novel heterocyclic compounds as hsp90-inhibitors
NZ561939A (en) 2005-03-30 2011-03-31 Conforma Therapeutics Corp Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors
CN102002043B (en) * 2010-11-16 2012-10-24 江苏科技大学 Method for synthesizing 6-methoxy group purine derivative in presence of 4-aminopyridine as catalyst
CN102633767B (en) * 2012-04-09 2013-10-30 武汉工程大学 Preparation method of non-ionic type iodine contrast medium intermediate 2-isopropyl-5-carboxy-1, 3-dioxane
PT3504210T (en) * 2016-08-29 2021-04-19 H Hoffnabb La Roche Ag 7-substituted sulfonimidoylpurinone compounds for the treatment and prophylaxis of virus infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216141A (en) * 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
EP1019404A1 (en) 2000-07-19
NZ502994A (en) 2001-12-21
CN1269801A (en) 2000-10-11
WO1999012927A1 (en) 1999-03-18
CA2302630A1 (en) 1999-03-18
JP2001515900A (en) 2001-09-25
ID26937A (en) 2001-02-22
AUPO912997A0 (en) 1997-10-02
KR20010023890A (en) 2001-03-26

Similar Documents

Publication Publication Date Title
PL346905A1 (en) Antiviral purine derivatives
EP1187827A4 (en) Antiviral agents
IL144171A0 (en) Quinolinecarboxamides as antiviral agents
AU3289299A (en) Antiviral agents
EP1019404A4 (en) Purine acyclonucleosides as antiviral agents
IL125447A0 (en) Modified benzimidazole nucleosides as antiviral agents
HU9700116D0 (en) Difluorostatone antiviral agents
IL114267A0 (en) Antiviral agents
HUP0104827A3 (en) Antiviral nucleoside analogues
PL341819A1 (en) Antiviral agents
PL338454A1 (en) Lixofuranosilbenzimidazoles as antiviral agents
GB9820420D0 (en) Antiviral combinations
AU9261198A (en) Antiviral agent
ZA98566B (en) Antiviral agents
ZA975565B (en) Antiviral combinations
GB9820417D0 (en) Antiviral combinations
GB9712253D0 (en) Antiviral compound
GB9821000D0 (en) Antiviral combinations
GB9719866D0 (en) Antiviral Combinations
GB9719883D0 (en) Antiviral combinations
GB9820416D0 (en) Antiviral combinations
SI1117669T1 (en) Antiviral purine derivatives
ZA987267B (en) Nucleosides
AUPO906597A0 (en) Antiviral agents
AUPO912897A0 (en) Antiviral agents

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000411

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20010522

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20011128

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040401

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1029586

Country of ref document: HK